Next Article in Journal
Real-World Study of Tildrakizumab Survival in Psoriasis: Impact of Arthritis, Hypertension, and Prior Biologic Use
Previous Article in Journal
Three-Dimensional Bioprinting Techniques in Skin Regeneration: Current Insights and Future Perspectives
 
 
Correction to Life 2024, 14(6), 686.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Ziyanok-Demirtas, S. A Holistic In Silico and In Vivo Approach to Exploring the Antidiabetic, Antioxidant, and Hepatoprotective Properties of Rose of Sharon. Life 2024, 14, 686

by
Sedef Ziyanok-Demirtas
Department of Biology, Faculty of Science and Arts, Bursa Uludag University, Bursa 16059, Turkey
Life 2025, 15(5), 788; https://doi.org/10.3390/life15050788
Submission received: 30 April 2025 / Accepted: 8 May 2025 / Published: 15 May 2025

Error in Figure/Table

In the original publication [1], there was a mistake in Figures 3 and 5, as well as Table 1, when published. There was a typo in the unit. The corrected Figure 3 and Figure 5, as well as Table 1, appear below.
  • In Figure 3, the glucose unit has been corrected to mg/dL.
  • In Figure 5, only the liver and kidney Glutathione Peroxidase units have been corrected to ng/mL.
  • In Table 1, the MDA units for heart, muscle, liver, and kidney should be nmol/mg.

Error in Text

There was also an error in the Section 2.6, Preparation of Samples and Biochemical Testing, the second sentence of the second paragraph. The kit brand used was spelled incorrectly.
The original version stated the following:
The levels of insulin, superoxide dismutase (SOD), and glutathione peroxidase (GSH-Px) were measured in the plasma, heart, skeletal muscle, liver, and kidney using ELISA kits from Sunlong Biotech, Zhejiang, China.
The corrected version of the kits’ brand name stated as follows:
The levels of insulin, superoxide dismutase (SOD), and glutathione peroxidase (GSH-Px) were measured in the plasma, heart, skeletal muscle, liver, and kidney using ELISA kits from YL Biont (Shanghai, China).
The author states that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Ziyanok-Demirtas, S. A Holistic In Silico and In Vivo Approach to Exploring the Antidiabetic, Antioxidant, and Hepatoprotective Properties of Rose of Sharon. Life 2024, 14, 686. [Google Scholar] [CrossRef] [PubMed]
Figure 3. Food and fluid intake, body weight, and blood glucose changes over four weeks in both control and experimental groups of rats. a: Compared with control. b: Compared with diabetes group. Statistical significance: * p < 0.05, C: Control; C + HSE: Control + Hibiscus syriacus extract; D: Diabetes; D + HSE: Diabetes + Hibiscus syriacus extract.
Figure 3. Food and fluid intake, body weight, and blood glucose changes over four weeks in both control and experimental groups of rats. a: Compared with control. b: Compared with diabetes group. Statistical significance: * p < 0.05, C: Control; C + HSE: Control + Hibiscus syriacus extract; D: Diabetes; D + HSE: Diabetes + Hibiscus syriacus extract.
Life 15 00788 g003
Figure 5. Glutathione peroxidase (GSH-PX) and superoxide dismutase (SOD) in control and experimental groups of rats. Values are expressed as mean ± SEM for rats each group (n = 9). a: Compared with control. b: Compared with diabetes group. Statistical significance: * p < 0.05. GSH-Px: Glutathione peroxidase; SOD: superoxide dismutase; C: Control; C + HSE: Control + Hibiscus syriacus extract; D: Diabetes; D + HSE: Diabetes + Hibiscus syriacus extract.
Figure 5. Glutathione peroxidase (GSH-PX) and superoxide dismutase (SOD) in control and experimental groups of rats. Values are expressed as mean ± SEM for rats each group (n = 9). a: Compared with control. b: Compared with diabetes group. Statistical significance: * p < 0.05. GSH-Px: Glutathione peroxidase; SOD: superoxide dismutase; C: Control; C + HSE: Control + Hibiscus syriacus extract; D: Diabetes; D + HSE: Diabetes + Hibiscus syriacus extract.
Life 15 00788 g005
Table 1. Malondialdehyde (MDA) control and experimental groups of rats. Values are expressed as mean ± SEM for rats each group (n = 9).
Table 1. Malondialdehyde (MDA) control and experimental groups of rats. Values are expressed as mean ± SEM for rats each group (n = 9).
CC + HSEDD + HSE
Plasma MDA (nmol/mL)2.2 ± 0.12.4 ± 0.57.0 ± 0.4 a*3.0 ± 0.1 b*
Heart MDA (nmol/mg)125.7 ± 1.4105.4 ± 1.1136.2 ± 1.3 a*111.1 ± 1.3 b*
Muscle MDA (nmol/mg)105.0 ± 1.196.3 ± 2.4148.3 ± 2.4 a**128.6 ± 4.5 b*
Liver MDA (nmol/mg)124.0 ± 1.4118.0 ± 3.1168.5 ± 4.1 a**145.8 ± 3.6 b**
Kidney MDA (nmol/mg)134.4 ± 1.597.2 ± 1.7 a*174.9 ± 2.4 a**118.3 ± 3.1 b**
a: Compared with control. b: Compared with diabetes group. Statistical significance: * p < 0.05, ** p < 0.01. MDA: Malondialdehyde, C; Control C + HSE; Control + Hibiscus syriacus extract, D; Diabetes, D + HSE; Diabetes + Hibiscus syriacus extract.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Ziyanok-Demirtas, S. Correction: Ziyanok-Demirtas, S. A Holistic In Silico and In Vivo Approach to Exploring the Antidiabetic, Antioxidant, and Hepatoprotective Properties of Rose of Sharon. Life 2024, 14, 686. Life 2025, 15, 788. https://doi.org/10.3390/life15050788

AMA Style

Ziyanok-Demirtas S. Correction: Ziyanok-Demirtas, S. A Holistic In Silico and In Vivo Approach to Exploring the Antidiabetic, Antioxidant, and Hepatoprotective Properties of Rose of Sharon. Life 2024, 14, 686. Life. 2025; 15(5):788. https://doi.org/10.3390/life15050788

Chicago/Turabian Style

Ziyanok-Demirtas, Sedef. 2025. "Correction: Ziyanok-Demirtas, S. A Holistic In Silico and In Vivo Approach to Exploring the Antidiabetic, Antioxidant, and Hepatoprotective Properties of Rose of Sharon. Life 2024, 14, 686" Life 15, no. 5: 788. https://doi.org/10.3390/life15050788

APA Style

Ziyanok-Demirtas, S. (2025). Correction: Ziyanok-Demirtas, S. A Holistic In Silico and In Vivo Approach to Exploring the Antidiabetic, Antioxidant, and Hepatoprotective Properties of Rose of Sharon. Life 2024, 14, 686. Life, 15(5), 788. https://doi.org/10.3390/life15050788

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop